Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/30/2011 | EP2390329A1 MicroRNA molecules |
11/30/2011 | EP2390328A1 MicroRNA molecules |
11/30/2011 | EP2390270A1 Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
11/30/2011 | EP2390262A1 Synthetic chemokine receptor ligands and methods of use thereof |
11/30/2011 | EP2390261A2 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof |
11/30/2011 | EP2390256A1 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes |
11/30/2011 | EP2389945A1 Pharmaceutical composition comprising AVE0010 and insulin glargine |
11/30/2011 | EP2389944A1 Use of IL-28 and IL-29 to treat cancer |
11/30/2011 | EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases |
11/30/2011 | EP2389942A1 Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof |
11/30/2011 | EP2389941A1 Growth-hormone secretagogues |
11/30/2011 | EP2389930A1 Novel composition for tumor growth control |
11/30/2011 | EP2389389A1 Stable growth hormone compounds |
11/30/2011 | EP2389388A2 Treatment for obesity |
11/30/2011 | EP2389205A2 Bioactive grafts and composites |
11/30/2011 | EP2389192A2 Stabilized fc polypeptides with reduced effector function and methods of use |
11/30/2011 | EP2389191A2 Expression of neuropeptides in mammalian cells |
11/30/2011 | EP2389190A2 Fgf21 derivatives with albumin binder a-b-c-d-e- and their use |
11/30/2011 | EP2389189A1 Method for the prevention and treatment of diastolic dysfunction employing an apolipoproteina1 (apoa1) mimetic peptide/phospholipid complex |
11/30/2011 | EP2389071A1 Biofilm-removing antimicrobial compositions and uses thereof |
11/30/2011 | EP2229408B1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
11/30/2011 | EP1904108B1 Ophthalmological formulation comprising methylsulfonylmethane and ciprofloxacin |
11/30/2011 | EP1751192B1 Cross-linked antibodies |
11/30/2011 | EP1681302B1 Angiogenesis inhibitor, production process and use thereof |
11/30/2011 | EP1677818B1 Stable aqueous g-csf-containing compositions |
11/30/2011 | EP1664123B2 Large scale preparation of alpha-1 proteinase inhibitor and use thereof |
11/30/2011 | EP1613368B1 Carboxamide spirohydantoin cgrp receptor antagonists |
11/30/2011 | EP1545565B1 Compositions comprising mitotically inactivated allogenic fibroblasts and keratinocytes for use in tissue regeneration |
11/30/2011 | EP1329461B1 Method of eliminating human serum albumin polymers |
11/30/2011 | CN1997387B 用于促进肉型家禽生长的方法和组合物 The method for promoting the growth of meat-type poultry and compositions |
11/30/2011 | CN1656222B 反义iap核碱基寡聚物及其应用 Iap nucleobase antisense oligomer and its application |
11/30/2011 | CN102264765A 抗muc1抗体 Antibody anti muc1 |
11/30/2011 | CN102264429A 微针装置 Microneedle device |
11/30/2011 | CN102264383A 胞内细菌感染的处理 Intracellular bacterial infection treatment |
11/30/2011 | CN102264382A 抗生素协同作用 Antibiotic synergy |
11/30/2011 | CN102264381A 提供对疟原虫的长效免疫应答的用于疟疾的多组分疫苗 Provides long-lasting immune response to Plasmodium multicomponent vaccine for malaria |
11/30/2011 | CN102264380A 低浓度的营养组合物 Low concentrations of a nutritional composition |
11/30/2011 | CN102264379A 肌肉增强剂 Muscle enhancer |
11/30/2011 | CN102260728A 一种蜂王浆多肽及其用途 Polypeptides, and uses one kind of jelly |
11/30/2011 | CN102260698A 大肠杆菌中表达PTA-linker-thanatin融合蛋白及其抗癌研究 PTA-linker-thanatin fusion proteins expressed in E. coli and cancer research |
11/30/2011 | CN102260697A 融合表达重组制备人β干扰素 Fusion Expression of recombinant human β-interferon preparation |
11/30/2011 | CN102260653A Preparation and application method of PEG recombinant pig-human urate oxidase fusion protein |
11/30/2011 | CN102260632A 一种酵母工程菌、其制备方法与应用 Yeast engineering bacteria, their preparation and use |
11/30/2011 | CN102260353A 靶向性白细胞介素融合蛋白及其制备方法与应用 Protein and its preparation method and application integration targeting interleukin |
11/30/2011 | CN102260352A 靶向性白细胞介素融合蛋白及其制备方法与应用 Protein and its preparation method and application integration targeting interleukin |
11/30/2011 | CN102260344A 缺失型人β干扰素及其重组制备 Deficient recombinant human β-interferon and its preparation |
11/30/2011 | CN102260343A 重组人g-csf二聚体在治疗神经损伤疾病中的用途 Recombinant human g-csf dimer in the treatment of nerve injury diseases in |
11/30/2011 | CN102260342A 重组缺失型人角质细胞生长因子Ⅰ型的化学偶联物 Deficient recombinant human keratinocyte growth factor Ⅰ type of chemical conjugates |
11/30/2011 | CN102260340A 五味子蛋白及其制备方法和药物用途 Schisandra protein and its preparation method and drug use |
11/30/2011 | CN102260325A Antibacterial peptide NX-16, and preparation method and application thereof |
11/30/2011 | CN102260324A 一种炎症前期趋化因子拮抗肽及其制备方法和应用 An inflammatory chemokine antagonistic pre-peptide and its preparation method and application |
11/30/2011 | CN102260321A 抗菌肽的多聚体形式 Multimeric form of antimicrobial peptides |
11/30/2011 | CN102260320A 具有抗肿瘤活性的化合物及其制备方法 Has the compounds and methods of anti-tumor activity |
11/30/2011 | CN102260319A 一种新型铂配合物、制备方法及用途 A new platinum complexes, preparation and use |
11/30/2011 | CN102258784A 用于预防和治疗败血症的方法与组合物 For the prevention and treatment of sepsis methods and compositions |
11/30/2011 | CN102258771A 重组水蛭素在防治糖尿病性白内障中的应用 Application of recombinant hirudin in the prevention and treatment of diabetic cataract |
11/30/2011 | CN102258770A 一种安全高效的冻干纤维蛋白封闭剂及其制备方法 A safe and effective freeze-dried fibrin sealant and its preparation method |
11/30/2011 | CN102258769A Sirt1在制备保护心肌细胞的药物中的用途 Sirt1 protect cardiomyocytes in the preparation of a medicament |
11/30/2011 | CN102258768A 重组人白介素15在治疗肾癌病症药物中的应用 Recombinant human interleukin-15 in the treatment of kidney disease drug application |
11/30/2011 | CN102258767A 促进伤口愈合的组合物 Promote wound healing compositions |
11/30/2011 | CN102258766A Nkx2.5在制备保护心肌细胞的药物中的用途 Nkx2.5 in the preparation of a medicament for protecting cardiomyocytes uses |
11/30/2011 | CN102258765A 一种硫酸粘杆菌素预混剂的制备方法 Preparation method of colistin premixes |
11/30/2011 | CN102258764A 21(r)阿加曲班的应用 21 (r) applications argatroban |
11/30/2011 | CN102258708A 一种养生酒及其制备方法 A wine and its preparation method and health |
11/30/2011 | CN102258486A 一种相思子蛋白纳米粒及其制备方法 A protein nanoparticles and preparation method abrin |
11/30/2011 | CN102258483A 一种抗血栓的重组巴曲酶冻干制剂 An anti-thrombotic recombinant batroxobin lyophilized preparation |
11/30/2011 | CN102258481A 一种联合高压静电液滴法和层层自组装法制备自组装载药微球的方法 A joint high-voltage electrostatic droplet method and the layers of self-assembled group prepared microspheres loaded method since |
11/30/2011 | CN102258479A 一种骨钙素的注射用缓释微球制剂 One kind of osteocalcin injectable sustained release microsphere preparation |
11/30/2011 | CN102258464A 高浓度抗体和蛋白制剂 High concentrations of antibody and protein formulations |
11/30/2011 | CN101919813B Method for preparing chitosan nanoparticles with recombinant human endostar for injection |
11/30/2011 | CN101889983B PEG-PLGA nanoparticle carrying recombinant human vascular endothelial inhibitor and preparation method thereof |
11/30/2011 | CN101716161B 一种胸腺肽壳聚糖微球口服药物制剂及其制备方法 Chitosan microspheres oral pharmaceutical formulation and preparation of thymosin |
11/30/2011 | CN101638431B 能与NKp80 受体结合的多肽及其应用 With NKp80 receptor binding polypeptides and their Applications |
11/30/2011 | CN101618023B 一种制备微粉化蛋白的方法 A method for preparing a protein powder |
11/30/2011 | CN101575365B 一种抗病毒蛋白及其制备方法和应用 An anti-viral protein and its preparation method and application |
11/30/2011 | CN101503727B 三角帆蚌酶解多肽及其制备和应用 Cumingii enzymatic peptides and their preparation and use |
11/30/2011 | CN101502649B 一种脂质体流感疫苗 Liposome influenza vaccine |
11/30/2011 | CN101444476B 新微球和其生产方法 The new microspheres and its production method |
11/30/2011 | CN101429231B 一种抗高血压活性三肽及其制备方法和应用 An anti-hypertensive activity tripeptide and its preparation method and application |
11/30/2011 | CN101376022B 含聚乙二醇降纤酶的药物组合物 Containing polyethylene glycol defibrase pharmaceutical compositions |
11/30/2011 | CN101098707B 抗生素107891、其因子a1和a2、可药用盐和组合物及其用途 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions and uses thereof |
11/29/2011 | US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA) |
11/29/2011 | US8067569 Splice-region antisense composition and method |
11/29/2011 | US8067567 Modified tert promoter with enhanced tumor-specificity and strength and recombinant vector comprising the same |
11/29/2011 | US8067563 Tumor suppressor gene, p471NG3 |
11/29/2011 | US8067554 separating speptide and related impurities by elution in a solution comprising an organic modifier, water, optionally a salt component, and a buffer, with a linear or step gradient or isocratically in salt component and/or with a linear or step pH-gradient or at a constant pH value |
11/29/2011 | US8067553 PEG-urate oxidase conjugates and use thereof |
11/29/2011 | US8067545 Isolated antibodies against biologically active leptin-related peptides |
11/29/2011 | US8067543 Factor VIII polymer conjugates |
11/29/2011 | US8067540 Human ALEX1 proteins |
11/29/2011 | US8067538 Gene related to growth promoting function of acetic acid bacterium, acetic acid bacterium bred using the gene and method for producing vinegar using the acetic acid bacterium |
11/29/2011 | US8067537 Composition and method for treatment of stomatitis |
11/29/2011 | US8067535 Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes |
11/29/2011 | US8067534 Carbon nanotube binding peptides |
11/29/2011 | US8067533 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
11/29/2011 | US8067532 Modifications of peptide compositions to increase stability and delivery efficiency |
11/29/2011 | US8067530 Scytovirin domain 1 related polypeptides |
11/29/2011 | US8067472 Methods of treating Hodgkin's and non-Hodgkin's lymphoma |
11/29/2011 | US8067438 Hepatitis C inhibitor compounds |
11/29/2011 | US8067433 Methods, compositions, and kits for the treatment of ophthalmic disorders |